ArticleLeukemia2022

Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2.

Jing Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.